These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 4117569)

  • 21. LE cell test and anti-nuclear antibody test in diagnosis of systemic lupus erythematosus.
    Burrows S; Domako E
    J Med Soc N J; 1971 Aug; 68(8):647-9. PubMed ID: 4107136
    [No Abstract]   [Full Text] [Related]  

  • 22. Diagnostic studies in patients with systemic lupus erythematosus.
    Forman MD; Kaplan D
    Prim Care; 1978 Mar; 5(1):133-42. PubMed ID: 77535
    [No Abstract]   [Full Text] [Related]  

  • 23. [Diagnostic and therapeutic possibilities in the early stage of systemic lupus erythematosus].
    Goebel KM; Krause A; Leyhe A; Klepzig M; Kolb G; Kohl FV
    Internist (Berl); 1986 Mar; 27(3):175-84. PubMed ID: 3519504
    [No Abstract]   [Full Text] [Related]  

  • 24. Limitations of antinuclear antibody tests (HEp-2) are overcome with the autoimmune target test (IT-1) in systemic lupus erythematosus.
    Jearn LH; Kim DA; Kim TY
    J Rheumatol; 2009 Aug; 36(8):1833-4. PubMed ID: 19671822
    [No Abstract]   [Full Text] [Related]  

  • 25. [Le cells in the "skin window" in patients with systemic lupus erythematosus].
    Kozlovskaia LV; Tareeva IE; Tuganbekova SK; Ianushkevich TN
    Ter Arkh; 1988; 60(7):88-90. PubMed ID: 2463694
    [No Abstract]   [Full Text] [Related]  

  • 26. [Etiology and pathogenesis of systemic lupus erythematosus].
    Carbajal N; Mintz G; Fraga A; Orozco JH
    Prensa Med Mex; 1973; 38(7):234-42. PubMed ID: 4133128
    [No Abstract]   [Full Text] [Related]  

  • 27. [Evaluation of indirect immunofluorescence test by Weller and Coons for demonstration of antinuclear factors].
    Nebe H
    Dermatol Monatsschr; 1970 Oct; 156(10):913-8. PubMed ID: 4927926
    [No Abstract]   [Full Text] [Related]  

  • 28. [General practice-relevant diagnostic and differential diagnostic aspects of collagen diseases. 1: Systemic lupus erythematosus].
    Apostoloff E; Sönnichsen N
    Z Arztl Fortbild (Jena); 1987; 81(8):385-7. PubMed ID: 3497490
    [No Abstract]   [Full Text] [Related]  

  • 29. Diseases in which antinuclear antibody and-or rheumatoid factor are usually present. (Rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis).
    Sheon RP; Kirsner AB
    Med Times; 1973 Feb; 101(2):97-113. PubMed ID: 4539866
    [No Abstract]   [Full Text] [Related]  

  • 30. Autoantibody determination in the diagnosis of systemic lupus erythematosus.
    Kurien BT; Scofield RH
    Scand J Immunol; 2006 Sep; 64(3):227-35. PubMed ID: 16918691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Differential diagnosis of initial manifestations of systemic lupus erythematosus].
    Schwick N; Schmitz S; Dellanna F; Neveling M; Gheorghiu T
    Med Klin (Munich); 1993 Feb; 88(2):85-7. PubMed ID: 8450814
    [No Abstract]   [Full Text] [Related]  

  • 33. [Lupus induced by isoniazid].
    Gaultier C; Griscelli C; Hayem F; Plus A; Mozziconacci P
    Ann Pediatr (Paris); 1972; 19(6):459-68. PubMed ID: 4538363
    [No Abstract]   [Full Text] [Related]  

  • 34. [Correlation between the presence of antibodies to native DNA and the occurrence of the LE phenomenon in patients with visceral lupus erythematosus].
    Marczak M; Kardaszewicz E; Sikora M
    Pol Tyg Lek; 1982 May; 37(12):339-40. PubMed ID: 6182556
    [No Abstract]   [Full Text] [Related]  

  • 35. Bullous pemphigoid associated with systemic lupus erythematosus.
    Jordon RE; Muller SA; Hale WL; Beutner EH
    Arch Dermatol; 1969 Jan; 99(1):17-25. PubMed ID: 4178218
    [No Abstract]   [Full Text] [Related]  

  • 36. Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?
    Shoenfeld Y; Meroni PL; Toubi E
    Curr Opin Rheumatol; 2009 Sep; 21(5):495-500. PubMed ID: 19593144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Crithidia luciliae and Farr assays for the detection of systemic lupus erythematosus.
    Burdash NM; Teti G; Papadopoulos V
    Ann Clin Lab Sci; 1983; 13(1):49-54. PubMed ID: 6340594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Demonstration of antinuclear antibodies in the epidermis of patients with progressive systemic sclerosis, generalized lupus erythematosus and dermatomyositis].
    Lamas Robles C; Mejía Arreguín S; Orozco Medina JH; González Mendoza A
    Rev Invest Clin; 1984; 36(2):115-9. PubMed ID: 6385174
    [No Abstract]   [Full Text] [Related]  

  • 39. [Biopathology of disseminated lupus erythematosus].
    Youinou P; Amoura Z
    Rev Prat; 1998 Mar; 48(6):603-8. PubMed ID: 9781129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The significance of immunologic tests in the diagnosis and differential diagnosis of systemic lupus erythematosus and rheumatoid arthritis].
    Guceva B; Grlickov M; Marina N; Calovski J; Cakalaroska D; Pusevski A
    Reumatizam; 1980; 27(1):1-4. PubMed ID: 6156480
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.